TransCure develops humanized mouse platforms in its own state-of-the-art and accredited biosafety level 2 and 3 (BSL2 and BSL3) animal facilities and laboratories, allowing to test infectious and non-infectious diseases such as HIV, HCV, HBV, Tuberculosis, inflammation and auto-immune diseases, rheumatoid arthritis, inflammatory bowel disease , multiple sclerosis, Lupus or parasitic diseases.
Domain: R&D Services and Technology Platforms, CRO (Contract Research Organization)
Therapeutics & Diagnostics, Antibodies / Anti-infectives
Therapeutics & Diagnostics, Cell Therapy / Stem Cells
Therapeutics & Diagnostics, Chemical Drug, small Molecules
Therapeutics & Diagnostics, Gene Therapy
Therapeutics & Diagnostics, Generics / Biosimilars
Therapeutics & Diagnostics, Vaccines
Contact: Av. de la Praille 26
1227 Carouge / GE
P: 079 955 64 56

http://www.transcurebiosciences.com
Find an actor

LS2 Annual Meeting 201812.02.2018

The biggest Life Sciences conference in Switzerland takes place at the University of Lausanne February 12-13, 2018

Comment la «Health Valley» séduit les start-ups

«Ici, il y a une vraie convergence entre les technologies informatiques et le domaine médical, créant un...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn